Capstone Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $906K | Sell |
4,005
-169
| -4% | -$38.2K | 0.03% | 621 |
|
|
2017
Q1 | $832K | Buy |
4,174
+365
| +10% | +$72.8K | 0.02% | 648 |
|
|
2016
Q4 | $694K | Sell |
3,809
-151
| -4% | -$27.5K | 0.02% | 735 |
|
|
2016
Q3 | $649K | Sell |
3,960
-440
| -10% | -$72.1K | 0.02% | 786 |
|
|
2016
Q2 | $629K | Buy |
4,400
+10
| +0.2% | +$1.43K | 0.02% | 796 |
|
|
2016
Q1 | $600K | Buy |
4,390
+530
| +14% | +$72.4K | 0.02% | 801 |
|
|
2015
Q4 | $535K | Buy |
3,860
+443
| +13% | +$61.4K | 0.02% | 879 |
|
|
2015
Q3 | $459K | Buy |
3,417
+473
| +16% | +$63.5K | 0.01% | 973 |
|
|
2015
Q2 | $443K | Buy |
2,944
+414
| +16% | +$62.3K | 0.01% | 1042 |
|
|
2015
Q1 | $342K | Buy |
2,530
+130
| +5% | +$17.6K | 0.01% | 1315 |
|
|
2014
Q4 | $289K | Sell |
2,400
-270
| -10% | -$32.5K | 0.01% | 1391 |
|
|
2014
Q3 | $303K | Buy |
2,670
+270
| +11% | +$30.6K | 0.01% | 1343 |
|
|
2014
Q2 | $287K | Buy |
2,400
+560
| +30% | +$67K | 0.01% | 1411 |
|
|
2014
Q1 | $236K | Sell |
1,840
-330
| -15% | -$42.3K | 0.01% | 1564 |
|
|
2013
Q4 | $268K | Sell |
2,170
-500
| -19% | -$61.8K | 0.01% | 1594 |
|
|
2013
Q3 | $314K | Buy |
+2,670
| New | +$314K | 0.01% | 1634 |
|